Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

The Obesity ETF (SLIM)

30.63
Delayed Data
As of 2:00pm ET
 +0.4553 / +1.51%
Today’s Change
21.51
Today|||52-Week Range
30.63
+36.29%
Year-to-Date

Investment Objective

The investment seeks investment results that correspond generally to the performance- before fees and expenses- of an index which is designed to track the performance of companies globally that are positioned to profit from servicing the obese- including biotechnology- pharmaceutical- health care and medical device companies whose business is focused on obesity and obesity related disease and companies focused on weight loss programs- weight loss supplements- or plus sized apparel. The fund invests at least 80% of its net assets in the stocks that comprise the Solactive Obesity Index. It is non-diversified.

Why Niche ETFs Are Terrible Investments
Dec 11 / TheStreet.com - Paid Partner Content
 

Performance

1 month+6.07% 3 years--
3 months+4.13% 5 years--
1 year+34.45% Since inception+13.38%
Data through 12/12/2017

Quote Details

Previous close$30.17
Open day’s range30.28 – 30.63
Net asset value (NAV)30.28 (12/11/2017)
Daily volume1,110
Average volume (3 months)707
Data as of 2:00pm ET, 12/12/2017

Peer Comparisonvs. Health ETFs

 SLIMCategory
Performance 5-yr return--+16.79%
Expense Gross exp ratio0.50%1.33%
Risk 5 year sharpe ratio--1.12
Net assets$3.0M$3.1B
Average market cap$9.5B$27.3B
Average P/E22.822.4
Dividend / Share--0.30%

Competitors

No competitors data available.

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
-- 20.23%
-- 20.07%
DXCM DexCom Inc5.66%
PODD Insulet Corp5.18%
-- 4.78%
DVA Davita Inc4.68%
-- 4.19%
HLF Herbalife Ltd3.89%
-- 3.30%
NXTM NxStage Medical Inc2.67%